A critical discovery in cancer investigation is emerging with the use of VHH fragments to re-engage mutated p53. This essential tumor inhibitor protein is frequently lost in many forms of malignancies, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research